CLASS II Drug recall · Reported 15 Aug 2018 · FDA Enforcement Report
Valsartan/HCTZ 160/25mg Tablets recalled by NuCare Pharmaceuticals
NuCare Pharmaceuticals is recalling Valsartan/HCTZ 160/25mg Tablets, distributed in California. The recall was initiated on 30 Jul 2018 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1038-2018
- FDA event ID
- 80701
- Recalling firm
- NuCare Pharmaceuticals, Orange, CA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 30 Jul 2018
- FDA classified
- 3 Aug 2018
- Reported
- 15 Aug 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
- Drug class
- Blood Pressure Medication
Timeline
| 30 Jul 2018 | Recall initiated by company | |
| 3 Aug 2018 | Classified by FDA | +4 days |
| 15 Aug 2018 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867,
Where it was distributed
Distributed to three customers in Fl and CA
Questions about this recall
Is Valsartan/HCTZ 160/25mg Tablets recalled?
Yes. NuCare Pharmaceuticals recalled Valsartan/HCTZ 160/25mg Tablets on 30 Jul 2018. The recall is Class II and its status is Terminated. Recall number D-1038-2018.
Why was it recalled?
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Which lots are affected?
Lot # T11443; Exp. 02/28/2019
Where was it sold?
Distributed to three customers in Fl and CA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from NuCare Pharmaceuticals
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Valsartan/HCTZ 160/12 recalled by NuCare Pharmaceuticals | NuCare Pharmaceuticals | Potency & Assay | CA |
| Drug | CLASS II | Valsartan/HCTZ 320/25mg Tablets recalled by NuCare Pharmaceuticals | NuCare Pharmaceuticals | Potency & Assay | CA |